These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37351921)

  • 21. Resource utilization and costs among patients with heart failure with reduced ejection fraction following a worsening heart failure event.
    Givertz MM; Yang M; Hess GP; Zhao B; Rai A; Butler J
    ESC Heart Fail; 2021 Jun; 8(3):1915-1923. PubMed ID: 33689217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus.
    Menzin J; Korn JR; Cohen J; Lobo F; Zhang B; Friedman M; Neumann PJ
    J Manag Care Pharm; 2010 May; 16(4):264-75. PubMed ID: 20433217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety of midodrine in patients with heart failure with reduced ejection fraction: a retrospective cohort study.
    Wu MJ; Chen CH; Tsai SF
    Front Pharmacol; 2024; 15():1367790. PubMed ID: 38510647
    [No Abstract]   [Full Text] [Related]  

  • 24. Association between use of β-blockers and outcomes in patients with heart failure and preserved ejection fraction.
    Lund LH; Benson L; Dahlström U; Edner M; Friberg L
    JAMA; 2014 Nov; 312(19):2008-18. PubMed ID: 25399276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic analysis of remote monitoring in patients with implantable cardioverter defibrillators or cardiac resynchronization therapy defibrillators in the Trento area, Italy.
    Marini M; Videsott L; Dalle Fratte CF; Francesconi A; Bonvicini E; Quintarelli S; Martin M; Guarracini F; Coser A; Benetollo PP; Bonmassari R; Boriani G
    Front Cardiovasc Med; 2023; 10():1151167. PubMed ID: 37304964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Remote Medication Monitoring System for Chronic Heart Failure Patients to Reduce Readmissions: A Two-Arm Randomized Pilot Study.
    Hale TM; Jethwani K; Kandola MS; Saldana F; Kvedar JC
    J Med Internet Res; 2016 Apr; 18(5):e91. PubMed ID: 27154462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost comparison across heart failure patients with reduced and preserved ejection fractions: Analyses of inpatient decompensated heart failure admissions.
    Olchanski N; Vest AR; Cohen JT; Neumann PJ; DeNofrio D
    Int J Cardiol; 2018 Jun; 261():103-108. PubMed ID: 29657034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of remote monitoring on long-term cardiovascular outcomes after cardioverter-defibrillator implantation.
    Portugal G; Cunha P; Valente B; Feliciano J; Lousinha A; Alves S; Braz M; Pimenta R; Delgado AS; Oliveira M; Ferreira RC
    Int J Cardiol; 2016 Nov; 222():764-768. PubMed ID: 27521554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economic Burden of Irritable Bowel Syndrome with Diarrhea: Retrospective Analysis of a U.S. Commercially Insured Population.
    Buono JL; Mathur K; Averitt AJ; Andrae DA
    J Manag Care Spec Pharm; 2017 Apr; 23(4):453-460. PubMed ID: 28345443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exercise-based cardiac rehabilitation for adults with heart failure.
    Long L; Mordi IR; Bridges C; Sagar VA; Davies EJ; Coats AJ; Dalal H; Rees K; Singh SJ; Taylor RS
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD003331. PubMed ID: 30695817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of change in iron status over time on clinical outcomes in heart failure according to ejection fraction phenotype.
    Fitzsimons S; Yeo TJ; Ling LH; Sim D; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Poppe K; Lund M; Devlin G; Troughton R; Lam CSP; Richards AM; Doughty RN
    ESC Heart Fail; 2021 Dec; 8(6):4572-4583. PubMed ID: 34592056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real-World Economic Outcomes During Time on Treatment Among Patients Who Initiated Sunitinib or Pazopanib as First Targeted Therapy for Advanced Renal Cell Carcinoma: A Retrospective Analysis of Medicare Claims Data.
    Vogelzang NJ; Pal SK; Ghate SR; Li N; Swallow E; Peeples M; Zichlin ML; Meiselbach MK; Perez JR; Agarwal N
    J Manag Care Spec Pharm; 2018 Jun; 24(6):525-533. PubMed ID: 29799328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two-year outcomes and cost for heart failure patients following discharge from the hospital after an acute heart failure admission.
    Olchanski N; Vest AR; Cohen JT; DeNofrio D
    Int J Cardiol; 2020 May; 307():109-113. PubMed ID: 31748189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.
    McCullough PA; Barnard D; Clare R; Ellis SJ; Fleg JL; Fonarow GC; Franklin BA; Kilpatrick RD; Kitzman DW; O'Connor CM; Piña IL; Thadani U; Thohan V; Whellan DJ;
    Clin Cardiol; 2013 Oct; 36(10):611-20. PubMed ID: 23929781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Remote monitoring for heart failure: Assessing the risks of readmission and mortality.
    Johnson AE; Bilderback AL; Boninger M; Beatty KY; Bellon J; Leopold MC; Watson AR; Ramani RN
    Am Heart J Plus; 2021 Oct; 10():100045. PubMed ID: 38550399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of remote monitoring of implanted cardioverter-defibrillator (ICD) and cardiac resynchronisation therapy device (CRT-D) patients on healthcare costs in the Silesian population: three-year follow-up.
    Buchta P; Tajstra M; Kurek A; Skrzypek M; Świetlińska M; Gadula-Gacek E; Wasiak M; Pyka Ł; Gąsior M
    Kardiol Pol; 2017; 75(6):573-580. PubMed ID: 28150288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Community-based care for the specialized management of heart failure: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(17):1-42. PubMed ID: 23074521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality outcomes, healthcare resource utilization and costs in Medicare patients with chronic heart failure with reduced ejection fraction with and without a worsening event.
    Mentz RJ; Pulungan Z; Kim S; Yang M; Teigland C; Hilkert R; Djatche LM
    J Med Econ; 2021; 24(1):698-705. PubMed ID: 33900874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Five-year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort.
    Chen S; Huang Z; Liang Y; Zhao X; Aobuliksimu X; Wang B; He Y; Kang Y; Huang H; Li Q; Yao Y; Lu X; Qian X; Xie X; Liu J; Liu Y
    ESC Heart Fail; 2022 Aug; 9(4):2336-2347. PubMed ID: 35437939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of telephone health coaching (Birmingham OwnHealth) on hospital use and associated costs: cohort study with matched controls.
    Steventon A; Tunkel S; Blunt I; Bardsley M
    BMJ; 2013 Aug; 347():f4585. PubMed ID: 23920348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.